本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Skye Bioscience Inc.

2.03
-0.1500-6.88%
盘后2.030.00000.00%16:05 EDT
成交量:27.57万
成交额:56.08万
市值:6,287.84万
市盈率:-2.78
高:2.18
开:2.17
低:1.95
收:2.18
数据加载中...
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2025/02/26

重要事件披露

Form 8-K - Current report
2024/12/24

SEC问询函

Form CORRESP - Correspondence
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/29

重要事件披露

Form 8-K - Current report
2024/10/24

重要事件披露

Form 8-K - Current report
2024/09/04

重要事件披露

Form 8-K - Current report
2024/08/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/03

重要事件披露

Form 8-K - Current report